304 results
8-K
EX-99.1
ENZ
Enzo Biochem, Inc.
13 Mar 24
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
4:31pm
for the Company’s products, cost of goods sold, other expenses, government regulations, litigation, and general business conditions. See Risk Factors
8-K
EX-99.1
ENZ
Enzo Biochem, Inc.
1 Feb 24
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
8:33am
expenses, government regulations, litigation, and general business conditions. See Risk Factors in the Company’s Form 10-K for the fiscal year ended July
8-K
EX-99.1
w4kzs7ps5b xw3r1l46
6 Sep 23
Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
6:12pm
8-K
EX-99.1
k9i8 6ni98we07
24 Jul 23
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
4:32pm
424B3
t54 9thrss
18 Jul 23
Prospectus supplement
9:42pm
424B3
q1lh u58hwc
21 Jun 23
Prospectus supplement
8:44pm
8-K
htk0r05x62f8q snbpa
30 May 23
Other Events
4:15pm
8-K
EX-4.1
4ayx2s6soscf
22 May 23
Entry into a Material Definitive Agreement
6:32am
8-K
EX-10.1
dpab5o3b nyx
22 May 23
Entry into a Material Definitive Agreement
6:32am